Navigation Links
Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs

Transferrin, a plasma protein found in blood, can be fused with large, protein-based drugs such as granulocyte colony-stimulating factor (G-CSF) to create a new oral compound that is capable of surviving the journey through the gastrointestinal (GI) tract and then able to cross over into the bloodstream to be used by the body, according to research from the University of Southern California School of Pharmacy.

This technology may allow for oral administration of drugs that previously could only be given by injection, notes Wei-Chiang Shen, Ph.D., professor and acting chair of the Department of Pharmaceutical Sciences. Shen, along with colleagues David Ann, Ph.D., professor of molecular pharmacology and toxicology, and Yun Bai, doctoral student in the Department of Pharmaceutical Sciences, wrote a paper on this research that will appear in the May 17 issue of the Proceedings of the National Academy of Sciences (PNAS), which is currently available online.

"Many of today's oral medications are made from small molecules, like amino acids or lipids, and their permeability allows them to be absorbed from the intestine into the body," says Shen. "On the other hand, protein-based drugs are large and bulky, which can prevent them from crossing the intestine and gaining access to the sites where they are needed. They are also very sensitive to digestive enzymes and may be destroyed by stomach acid before they can be absorbed." To sidestep the difficulty of getting these large protein drugs through the GI tract intact, pharmaceutical scientists have looked at other ways to deliver protein-based drugs-such as via needle-free injections or through inhalation. But, these delivery methods pose their own significant challenges. Ultimately, Shen and colleagues began to reconsider the possibilities of oral drug administration.

Their first breakthrough came when they began to recognize the potential uses of transferrin. "We discovered that transferrin can bind t
'"/>

Source:Eurekalert


Page: 1 2 3

Related biology news :

1. Live Recombinant Adenovirus Vaccine Technique Explored
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. The BIOS Initiative - open source biotechnology is born
5. Revolutionary nanotechnology illuminates brain cells at work
6. Study: homemade gene expression technology unreliable
7. First technology to remove prions that cause vCJD from blood launched
8. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
9. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
10. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
11. Vietnam war technology could aid elephant conservation

Post Your Comments:
(Date:11/23/2009)...producing some of the highest resolution images of...s have a deeper understanding how biomolecules man...d to a new treatment for kidney stones using biomo...v. 23 online edition of the journal Proceedings o...peptides interact with mineral surfaces by acceler...
(Date:11/23/2009)... new study by University of Alabama at Birmingham ... and co-existing medical conditions (co-morbidity)...ong African-Americans compared to Caucasians who a...ne Nov. 23 in Cancer , a journal of the American ...hough BMI and co-morbidity are independent predict...
(Date:11/23/2009)...w studies reveal in unprecedented detail how the r... new proteins and guide them toward their destinat...r dynamics flexible fitting (MDFF) to examine the ...ecular partners. , The first study, in Proceed...s the intimate signaling between the ribosome and ...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 1Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 2Liberty Screening Hires Top Sales Exec for Southeastern U S 56086 1Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2
...ted to increase usability and adoption of SMS and ...cations, MENLO PARK, Calif., Sept. 10 Promptu Sy...ve voice-powered mobile,applications, unveiled tod...and highly accurate voice dictation system. Using ...ognition (CSSR(TM)) technology, the system convert...
... on the Market, Stantum,s SMK Series Will Let Vend...e Multi-Touch Applications, SAN DIEGO, Sept. 23 ... pioneer developer of multi-touch sensing,technolo...pment board based,on its patented PMatrix(TM) resi...ultaneously move an unlimited number of fingers, n...
... Stevens Institute of Technology has been awarded... to support research and development into biomass ...warded by the DOE to various higher-education inst...ts. In total, the DOE will invest up to $4.4 milli... into how non-food feedstocks can be transformed i...
Other Biology News:Promptu Unveils High Accuracy Voice-to-Text Dictation for Mobile Phones at CTIA 2Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology 2Stevens awarded $1M for advanced biofuels research 2
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...,theNasdaqStockMarketthattradinginthecompany,scomm...25-NSEwillbefiledwiththe,SecuritiesandExchangeComm...ingonNasdaq,unlessthecompanyfilesanappealtotheNasd...chanappeal,which,willstaythesuspensionanddelisting...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...tday"motionsbytheU.S.BankruptcyCourtfortheDistrict...ledavoluntarypetitionfor,reliefunderChapter11ofthe... , TheordersissuedbytheBankruptcyCourtallowth...apter11proceedings.Inparticular,the,companyreceive...
(Date:11/24/2009)...sia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood...igationalnewdrugapplication(IND)foritsoralinsulinp...eatdiabetes.ThisIND,approvalallowsBiolaxytoinitiat...sordercharacteristicofhighbloodglucoseandpoor,meta...remicro-and,macro-vasculardiseases,lossofvision,ki...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
...cus Therapeutics,(Nasdaq: FOLD ), a biopharmaceut...nistered pharmacological chaperones for the treatm...d quarter 2008 financial results after,the regular... results,announcement will be followed by a live c.... EDT., Interested participants and investors may...
...ultiple Markets, Including Industrial ... 31 PURE Bioscience (Nasdaq:,PURE) today announce...distribution of PURE,s silver dihydrogen citrate (...TM) brand., (Logo: http://www.newscom.com/cgi-bi...nal Inc, a Minneapolis based chemical manufacturer...
...utlook, MELVILLE, N.Y., July 31 Gentiva Health,S...ng provider of,comprehensive home health services,... by double-digit increases in Medicare revenues an..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...he quarter ended June 29, 2008 included:, -- A 13...
Other Biology Technology:Amicus Therapeutics Announces Second Quarter 2008 Results Release Date 2PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 2PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 3PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 4Gentiva Reports Strong Second Quarter led by Home Health Segment 2Gentiva Reports Strong Second Quarter led by Home Health Segment 3Gentiva Reports Strong Second Quarter led by Home Health Segment 4Gentiva Reports Strong Second Quarter led by Home Health Segment 5Gentiva Reports Strong Second Quarter led by Home Health Segment 6Gentiva Reports Strong Second Quarter led by Home Health Segment 7Gentiva Reports Strong Second Quarter led by Home Health Segment 8Gentiva Reports Strong Second Quarter led by Home Health Segment 9Gentiva Reports Strong Second Quarter led by Home Health Segment 10Gentiva Reports Strong Second Quarter led by Home Health Segment 11Gentiva Reports Strong Second Quarter led by Home Health Segment 12
...mid-Based Deletion Machine is based on the simple,...developed by Goryshin and Reznikoff, and by York e...ns and inversions by intramolecular transposition ... plasmid vector. Although most researchers will be...
...romStreptomyces griseolusthat inhibits protein syn...tivity in eukaryote ribosomes. Reported to induce ...cytic leukemia cells, Jurkat cells, ventricular my...intracellular signals and immediate early gene ind...
VersArray Hybridization Chamber from Bio-Rad
...e-of-the-art separation system using the asymmetri...The Eclipse integrates easily with Wyatts multi-an...iDAWN Tristar, as well as the Optilab DSP. The com... distributions of the particles/molecules separate...
Biology Products: